A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural Hematoma
Recruiting now · Not applicable
Conditions studied: Chronic Subdural Hematoma, Surgical Procedures, Operative, Recurrence, Mortality, Drainage, Drainage/Methods, Drainage Procedure
In brief
Chronic subdural hematoma (CSDH) is a common disease. The main treatment is neurosurgical evacuation and subsequent hematoma drainage. However, consensus on the optimal drain placement site, and whether the drainage should be active or passive, is lacking. The aim of the current study is to test the hypothesis that 24 hours active subperiosteal drainage is non-inferior to 24 hours passive subdural drainage after single burr hole evacuation of a unilateral CSDH. The study is a multicenter randomized non-inferiority trial encompassing all neurosurgical units in Denmark. Adult patients with symptomatic CSDH admitted to a Danish neurosurgical unit for single burr hole evacuation will be screened for inclusion. Patients who are not able to give informed consent, and patients with recurrent CSDH, known cerebrospinal fluid abnormalities, and other known brain pathologies will be excluded. Patients with bilateral CSDH will be registered as one case and treated similarly on both sides. Before surgical hematoma evacuation patients will be randomized to 24-hour passive subdural drainage or 24-hour active subperiosteal drainage. The patients included and the two study statisticians will be blinded. The primary outcome is a composite outcome of 90-day mortality and symptomatic CSDH recurrence. Secondary outcomes are 90-day simplified modified Rankin score (smRSq), and complications related to surgery or occurring during admission, including intracerebral hemorrhage due to misplaced drains, acute subdural hematoma, tension pneumocephalus, wound infection, drain seepage, subperiosteal hematoma, thromboembolic events, infections and seizures. Sample size simulations of non-inferiority with a threshold of 7% increased relative risk show that a total of 354 participants will be required to demonstrate a relative risk reduction of recurrent CSDH and mortality of 30% for the cohort receiving active subperiosteal drainage given a stable power above 80% with an alpha of 5%. The study inclusion period is estimated to last 2 years. Ethics approval for inclusion of competent patients has been obtained (N-20240009).
Key facts
- Study ID
- NCT06621407
- Run by
- Aalborg University Hospital
- People needed
- 354
- Starts
- 2025-09-01
- Expected to finish
- 2027-11-01
- Last updated by the study team
- 2025-11-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients (≥ 18 years).
- Patients with symptomatic CSDH confirmed on brain CT- or magnetic resonance imaging (MRI), admitted to a Danish neurosurgical department for surgical treatment.
- Patients undergoing a single burr-hole evacuation.
- Informed written and oral consent is taken prior to surgery.
You may not qualify if…
- Patients who are mentally incapacitated
- Patients with known abnormalities in their cerebrospinal fluid (protein and glucose levels, cell count, and type)
- Patients with changes or abnormalities in their normal cerebrospinal fluid dynamics, e.g., obstructive hydrocephalus, normal pressure hydrocephalus, intracranial hypotension, and ventricular peritoneal shunt.
- Patients with additional/previously intracranial pathology that requires/has required neurosurgical treatment (e.g., brain tumor, vascular malformation, abscess).
- Patients with recurrent CSDH or with previous craniotomy or other transcranial surgery (for any reason)
- Patients unable to give consent prior to surgery
Where it is running
- Department of Neurosurgery, Aalborg University Hospital — Aalborg, Denmark (enrolling)
- Department of Neurosurgery, Aarhus University Hospital — Aarhus, Denmark (enrolling)
- Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet — Copenhagen, Denmark (enrolling)
- Department of Neurosurgery, Odense University Hospital — Odense, Denmark (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.